In cells (tumour cells or antigen-presenting cells (APCs)), these abnormal proteins are degraded into short peptides (antigen epitopes) with high affinity for major histocompatibility complex (MHC) class I or MHC class II molecules, and are presented on the cell surface in the form of complexes. Here, HLA-C is linked to neoplasm.